3FDC Clinical Trial update

• The psychological functioning study being conducted by the CSIRO using 3FDC components of the GaRP (“Gastrointestinal Reprogramming” coated multicomponent complementary medicine) has been halted • Anatara was the sponsor for the CSIRO trial supported by grant funding to assess 3FDC effect on mild to moderate levels of depression, anxiety or stress related symptoms in participants without a gastr